Welcome to the Hardcore Husky Forums. Folks who are well-known in Cyberland and not that dumb.

BREAKING: Moderna says its coronavirus vaccine trial produced ‘robust’ immune response in all patien

insinceredawg
insinceredawg Member Posts: 5,117
in Tug Tavern
I think we could all agree this is good news. Might get some pushback from the anti-vaxxers though.
· Share on FacebookShare on Twitter
«13

Comments

  • MelloDawg
    MelloDawg Member Posts: 6,917
    PurpleThrobber said:

    That's nice. You all have fun with that shot.

    Have been fully vaccinated my whole life but I ain't taking that shit.


    How is Bill Gates supposed to find you then?
    · Share on FacebookShare on Twitter
  • PurpleThrobber
    PurpleThrobber Member Posts: 48,499 Standard Supporter
    MelloDawg said:

    PurpleThrobber said:

    That's nice. You all have fun with that shot.

    Have been fully vaccinated my whole life but I ain't taking that shit.


    How is Bill Gates supposed to find you then?
    His people can call my people and make an appointment.



    · Share on FacebookShare on Twitter
  • NorthwestFresh
    NorthwestFresh Member Posts: 7,972
    Moderna shares jump as much as 16% after company says its coronavirus vaccine trial produced 'robust' immune response

    Why not short it and make some inside money with a dubious claim. Somebody is getting rich once the vaccine doesn’t get to market and stock price craters.
    · Share on FacebookShare on Twitter
  • NorthwestFresh
    NorthwestFresh Member Posts: 7,972
    Ah, the money shot. $20 million a “fraction” of a long-term contribution. No wonder Fauci has mentioned that company by name. Cha-Ching. As someone who worked in pharma and medical for over a decade, expediting clinical studies on a vaccine used on humans is a horrible idea, btw.



    Dr. Anthony Fauci, the nation's top infectious disease expert, has often touted Moderna's potential vaccine.


    http://www.ddn-news.com/index.php?newsarticle=10450

    CAMBRIDGE, Mass.—A year after it attracted the largest private financing round ever for a biotechnology company, Moderna Therapuetics is receiving another major show of support for its messenger RNA (mRNA) technology. The Bill & Melinda Gates Foundation has announced a $20-million grant to Moderna to advance the development of an affordable mRNA-based cocktail of antibody therapeutics to help prevent human immunodeficiency virus (HIV) infection. The development efforts will be led by Valera, Moderna’s year-old infectious disease-focused subsidiary.

    Stéphane Bancel, CEO of Moderna, tells DDNews that the Gates Foundation grant will provide support for GLP toxicology studies, preparations for clinical trials and a Phase 1 study. “We are honored that the Bill & Melinda Gates Foundation has selected Moderna as a partner, recognizing the tremendous potential of our mRNA drug platform to address some of the world’s most widespread and urgent health concerns,” he says.

    The initial $20 million provided by the Gates Foundation grant could be just a fraction of a longer-term contribution. The Gates Foundation and Moderna have reached an agreement that could eventually lead to another $80 million in grants from the foundation. Bancel says that the additional funding could be used to advance the HIV antibody program if Phase 1 studies are successful, or it could also be used to launch new programs focused on developing mRNA-based antibody treatments for other infectious diseases.
    · Share on FacebookShare on Twitter